ACYLIN THERAPEUTICS

Acylin Therapeutics is the first company focused on developing inhibitors of cellular acetylation, an enzymatic mechanism fundamental to the molecular pathology of cancer, metabolic disease, and neurodegeneration. Recent discoveries by Acylin founders and other investigators have revealed protein acetylation as a cellular signal transduction regulator potentially as ubiquitous and important as phosphorylation by kinase enzymes. The Company has developed a platform technology to design specific acyltransferase inhibitors based on crystal structures, novel medicinal chemical approaches, and mechanistic understanding. Acylin has prioritized the p300 and CBP histone acetyl transferases [HATs] for initial drug discovery.

#People #Financial #More

ACYLIN THERAPEUTICS

Industry:

Biotechnology Manufacturing Pharmaceutical Therapeutics

Founded:

2009-01-01

Address:

Seattle, Washington, United States

Country:

United States

Total Employee:

Status:

Active

Total Funding:

6.4 M USD

Technology used in webpage:

PHP

Current Advisors List

lee-babiss_image

Lee Babiss Board of Directors @ Acylin Therapeutics
Board_member

janis-naeve_image

Janis Naeve Board of Directors @ Acylin Therapeutics
Board_member

thong-le_image

Thong Le Board of Directors @ Acylin Therapeutics
Board_member

Current Employees Featured

lindsay-rayle_image

Lindsay Rayle
Lindsay Rayle Controller and Vice President of Operations @ Acylin Therapeutics
Controller and Vice President of Operations
2004-01-01

not_available_image

Suresh Jain
Suresh Jain Co-Founder, President & COO @ Acylin Therapeutics
Co-Founder, President & COO
2009-01-01

bard-geesaman_image

Bard Geesaman
Bard Geesaman Chief Technology Officer @ Acylin Therapeutics
Chief Technology Officer

david-schubert_image

David Schubert
David Schubert President and Chief Business Officer @ Acylin Therapeutics
President and Chief Business Officer

Founder

not_available_image

Suresh Jain

Investors List

amgen-ventures_image